http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2728821-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6fc2e72218aeeb26aea2a18eaa9eceb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b03c0146d0e2e5f51fabac23083782dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc688e8000304eb21f2a212ab71e9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de4cc1f55eb1d95bfe0553561db7f091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6a085852a7ae0f48480b3d56f94a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee79de09f2a64b7b8ab335681f517451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e87f741125ed49c6b8dc0c153d9a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca4837548f79b7000de1a00968ad085
publicationDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2728821-C1
titleOfInvention Method of treating acute respiratory distress syndrome by dalargin and a pulmonary surfactant
abstract FIELD: medicine; pharmacology.SUBSTANCE: invention refers to pharmacology and medicine and aims at treating acute respiratory distress syndrome (ARDS). Method of treating ARDS involves administering effective amounts of a pulmonary surfactant and a hexapeptide of formula H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH (I) or a pharmaceutically acceptable salt thereof into a mammal in need thereof.EFFECT: use of the invention enables higher clinical effectiveness in ARDS by combined use of a pulmonary surfactant and a hexapeptide of formula (I), which synergistically effectively reduces the risk of ARDS mortality.1 cl, 1 dwg, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2770364-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2772735-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745774-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2751488-C1
priorityDate 2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2672888-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2657416-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9835683-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426121892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826713

Total number of triples: 33.